Latest News of CTMX
CytomX Therapeutics Inc (CTMX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...
By Yahoo! Finance |
2 weeks ago
The CEO, Sean McCarthy, provided updates on CX-904 and CX-2051 programs, emphasizing dose escalation for CX-904 and progress into cohort five for CX-2051. Phase 1B decisions and updates are expected n...
CytomX Therapeutics, Inc. (CTMX): The Best One-Dollar Stock to Buy Now?
By Yahoo! Finance |
3 months ago
The article discusses the current stock market trends and focuses on CytomX Therapeutics, a biotech company listed under one-dollar stocks. Despite promising technologies, risks like financial runway ...
CytomX Therapeutics, Inc. (NASDAQ:CTMX) is definitely on the radar of institutional investors who own 47% of the company
By Yahoo! Finance |
4 months ago
Analyzing ownership data of a company like CytomX Therapeutics, Inc. can provide insights into future performance. Institutional investors hold a significant stake, influencing market decisions. Hedge...